| HOME >> BIOLOGY >> TECHNOLOGY |
reduced as a result.
(4) Overall Financial Situation of the first half 2007 Results Main business revenue for the six months ended June 30, 2007 was $2,539,658, gross profit was $1,606,501 and after-tax net profit was $1,262,141, a 351% increase year-over-year in 2006,or $0.014 per share. The total net cash flow was $2,204,416; net of operating cash flow was $1,475,289.
These data came from the Discussed Draft. PLEASE refer to the final version.
Forward-looking statement
Certain information contained in these materials are "forward-looking" information, such as projections, estimates, pro formas, or statements of intentions, expectations or plans. All forward-looking information are subject to known and unknown risks and uncertainties, many of which are outside of the control of the company. Consequently, actual results may, and probably will, differ materially from the results contemplated in such forward-looking information.
About China Bionanometer Industries Corporation
China Bionanometer Industries Corporation is a high-tech enterprise specialized in the research, development, production and sale of nanometer level health food, cosmetics, biological disinfection products, and traditional Chinese medicine, etc. The company has obtained state authentication for high and new technology enterprises and is also an academician enterprise in the high-tech field. As a high and new technology enterprise that takes scientific research as its base, profiting from the huge benefits brought by technological innovation, the company establishes an efficient scientific research development system that allows the continuation of the pursuit for newer technologies and industrial development by creating a people-orientated and innovative environment that follows the modern management model.
Safe Harbor Statement
This announcement contains forward-looking statements within the
meaning of the safe harbor provisions of
'/>"/>
| SOURCE Xi'an Landway Bionanometer Technology Co., Ltd. Copyright©2008 PR Newswire. All rights reserved |